We educate healthcare providers, program managers, researchers, policymakers, and others to build capacity in addressing issues impacting people who use drugs. We have a selection of education programs—in-person and online—on topics including hepatitis C, opioid agonist treatment and harm reduction (coming soon).
All of our education programs are adaptable and can be tailored to meet the diverse needs of any country or audience. Additionally, our expertise allows us to curate bespoke education initiatives in collaboration with partners. Would you like to discuss potential education projects? Contact us at [email protected].
Our education projects
Hepatitis C in Drug and Alcohol Settings Program
Our Hepatitis C in Primary Care and Drug and Alcohol Settings Education Program is designed for healthcare practitioners working in primary care or drug and alcohol settings or working with people who use drugs. It is available in 14 countries and multiple languages globally.
Hepatitis C Intervention Symposia
INHSU’s Intervention Symposia focuses on the practical implementation of evidence-based HCV interventions such as point-of-care testing, dried blood spot testing, peer support, patient navigation and case finding.
Hepatitis C online learning modules
Tailored for 14 countries, our online learning modules improve understanding of hepatitis C in four key areas; epidemiology, assessment, treatment and management. These modules are suited to medical practitioners, nurses, allied health or other health professionals looking to increase their country-specific knowledge on hepatitis C.